Wilhelmus Groenhuysen
2019
In 2019, Wilhelmus Groenhuysen earned a total compensation of $4.2M as Chief Financial Officer at NovoCure, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $396,396 |
|---|---|
| Option Awards | $2,202,814 |
| Salary | $600,600 |
| Stock Awards | $962,485 |
| Other | $24,789 |
| Total | $4,187,084 |
Groenhuysen received $2.2M in option awards, accounting for 53% of the total pay in 2019.
Groenhuysen also received $396.4K in non-equity incentive plan, $600.6K in salary, $962.5K in stock awards and $24.8K in other compensation.
Rankings
In 2019, Wilhelmus Groenhuysen's compensation ranked 2,817th out of 13,971 executives tracked by ExecPay. In other words, Groenhuysen earned more than 79.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,817 out of 13,971 | 80th |
Division Manufacturing | 1,020 out of 5,695 | 82nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 138 out of 832 | 83rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 71 out of 535 | 87th |
Industry Surgical and Medical Instruments and Apparatus | 43 out of 350 | 88th |
Source: SEC filing on April 27, 2020.
Groenhuysen's colleagues
We found four more compensation records of executives who worked with Wilhelmus Groenhuysen at NovoCure in 2019.